Stem cell therapies for enteric neuropathies

STEM CELL THERAPIES FOR ENTERIC NEUROPATHIES

Dr Lincon Stamp,
Senior Research Fellow & Group Leader,
Department of Anatomy and Physiology,
School of Biomedical Sciences,
The University of Melbourne, Victoria, Australia

RESEARCHER PROFILE
Filmed in Melbourne, Australia | October 2025

Dr Stamp is a Group Leader in the Department of Anatomy and Physiology at the University of Melbourne, Australia. Dr Stamp’s PhD research (with Prof Martin Pera, Monash University) focused on the derivation of hepatopancreatic progenitors from human embryonic stem cells. He then joined the lab of Dr Don Newgreen at the Murdoch Childrens Research Institute where he began working on development of the enteric nervous system (ENS), before joining Prof Heather Young’s lab at the University of Melbourne, where he focused on developing a stem cell therapy to treat gut motility disorders such as the paediatric enteric neuropathy Hirschprung disease.

His lab, which he runs together with Dr Marlene Hao, is now focused on the development, plasticity, and cell and gene therapies for the digestive system, with a particular focus on the enteric nervous system.

Dr Stamp has a strong national and international network of collaborators, including key clinical and consumer connections, and has published high impact studies in top tier journals including Gastroenterology, JCI and Nature Reviews Gastroenterology and Hepatology.

He has had success at securing significant government (ARC, MRFF), philanthropic (NSCFA, REACH Foundation) and industry (Takeda Pharmaceuticals) funding, has strong ties within the Australian and international stem cell communities, and is the currently the President of the Australasian Society for Stem Cell Research (ASSCR).

Source: Supplied

Scroll to top